SCHEMBL14920459

SCHEMBL14920459

NC(=O)C[CH]c1ccc(Cl)c(Oc2ccc(-c3cnco3)cc2)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.46
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NOTUM Q6P988 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
PORCN Q9H237 1/20 0.36
RHEB Q15382 1/20 0.36
KDM4E B2RXH2 3/20 0.35
NPC1 O15118 3/20 0.35
PKM P14618 3/20 0.35
CHEK2 O96017 2/20 0.34
ALDH1A1 P00352 2/20 0.33
RAB9A P51151 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HTT P42858 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
PARP1 P09874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14920652 0.81 RAF1 (0.33) MEN1KMT2ACYP3A4RHEBNPC1
SCHEMBL14920471 0.80 PARP10 (0.37) CYP3A4RHEBCHEK2ALDH1A1TDP1
SCHEMBL14920886 0.79 PARP10 (0.43) KMT2ARHEBKDM4ECHEK2ALDH1A1
SCHEMBL14920130 0.79 RHEB (0.44) MEN1KMT2ARHEBTDP1HTT
SCHEMBL14920397 0.76 MET (0.31)
SCHEMBL14920790 0.75 PTPN7 (0.41) MEN1KMT2ANPC1PKMCHEK2
SCHEMBL14920644 0.74 MAPT (0.37) KCNH2
SCHEMBL16117170 0.73
SCHEMBL16117169 0.73
SCHEMBL14920631 0.73 KDM4E (0.37) KMT2AKDM4ENPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773613-A1 SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION Astex Therapeutics Limited (GB) 2014-09-10 EP disclosed
WO-2013064538-A1 SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION ASTEX THERAPEUTICS LIMITED (GB) 2013-05-10 WO disclosed